Anat Achiron
Impact in
- Pathology and Forensic Medicine top 0.1%
- Multiple Sclerosis Research Studies
- Neurology top 0.5%
- Peripheral Neuropathies and Disorders
Papers in
-
- Multiple Sclerosis Research Studies 176
- Neurology 78
- Peripheral Neuropathies and Disorders 52
- Co-authors
- Yoram BarakMichael GurevichAlon KalronMark DolevUri GivonR. AchironDavid MagalashviliMathilda Mandel
- Journals
- Neurology (21 papers)Journal of Neuroimmunology (13 papers)Multiple Sclerosis and Related Disorders (12 papers)Multiple Sclerosis Journal (11 papers)Journal of the Neurological Sciences (11 papers)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Anat Achiron
313 papers receiving 8.4k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Pathology and Forensic Medicine 4.3k
- Neurology 2.0k
- Physical Therapy, Sports Therapy and Rehabilitation 379
- Psychiatry and Mental health 1.2k
- Neurology 553
Countries citing papers authored by Anat Achiron
This map shows the geographic impact of Anat Achiron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anat Achiron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anat Achiron more than expected).
Fields of papers citing papers by Anat Achiron
This network shows the impact of papers produced by Anat Achiron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anat Achiron. The network helps show where Anat Achiron may publish in the future.
Co-authors
The 25 scholars most cited alongside Anat Achiron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 15 | |
| 7 | 2016 | 6 | |
| 8 | Pregnancy outcomes in patients with active RRMS who received alemtuzumab in the clinical development program | 2015 | 9 |
| 9 | 2006 | 126 | |
| 10 | 2005 | 7 | |
| 11 | 2005 | 90 | |
| 12 | 2003 | 19 | |
| 13 | 2003 | 198 | |
| 14 | 2001 | 1 | |
| 15 | 2000 | 65 | |
| 16 | 1998 | 5 | |
| 17 | 1995 | 4 | |
| 18 | 1994 | 98 | |
| 19 | 1994 | 24 | |
| 20 | 1988 | 4 |
About Anat Achiron
Anat Achiron is a scholar working on Pathology and Forensic Medicine, Neurology, Immunology, Rheumatology and Psychiatry and Mental health, having authored 320 papers that have together received 8.6k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (176 papers), Peripheral Neuropathies and Disorders (52 papers), Immunotherapy and Immune Responses (21 papers), Cytokine Signaling Pathways and Interactions (21 papers), Systemic Lupus Erythematosus Research (19 papers), Autoimmune and Inflammatory Disorders Research (17 papers), Cerebral Palsy and Movement Disorders (16 papers) and Polyomavirus and related diseases (15 papers). The work is most often cited by research in Pathology and Forensic Medicine (4.3k citations), Neurology (2.0k citations), Physical Therapy, Sports Therapy and Rehabilitation (379 citations), Psychiatry and Mental health (1.2k citations) and Neurology (553 citations). Anat Achiron has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Yoram Barak, Michael Gurevich, Alon Kalron, Mark Dolev, Uri Givon, R. Achiron, David Magalashvili, Mathilda Mandel, I Sarova-Pinhàs and Zeevi Dvir. Their work appears in journals such as Neurology, Journal of Neuroimmunology, Multiple Sclerosis and Related Disorders, Multiple Sclerosis Journal and Journal of the Neurological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.